Marinomed Biotech AG (VIE:MARI)
Austria · Delayed Price · Currency is EUR 9.20
-0.05 (-0.54%)
Jun 26, 2026, 5:35 PM CET
Marinomed Biotech AG Market Cap
Marinomed Biotech AG has a market cap or net worth of €18.39 million as of June 26, 2026. Its market cap has decreased by -17.27% in one year.
Market Cap
18.39M
Enterprise Value
29.00M
Revenue
7.96M
Ranking
n/a
PE Ratio
0.94
Stock Price
€9.20
Market Cap Chart
Since February 1, 2019, Marinomed Biotech AG's market cap has decreased from 95.76M to 18.39M, a decrease of -80.80%. That is a compound annual growth rate of -19.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 18.39M | -47.67% |
| Dec 30, 2025 | 35.14M | 31.74% |
| Dec 30, 2024 | 26.67M | -39.87% |
| Dec 29, 2023 | 44.36M | -47.78% |
| Dec 30, 2022 | 84.95M | -34.78% |
| Dec 30, 2021 | 130.25M | -25.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RWT AG | 34.29M |
| Stadlauer Malzfabrik Aktiengesellschaft | 31.36M |
| K2g Holding AG | 29.25M |
| RATH Aktiengesellschaft | 29.25M |
| SW Umwelttechnik Stoiser & Wolschner AG | 28.89M |
| Warimpex Finanz- und Beteiligungs AG | 27.49M |
| Enry S Island Spa Sb | 23.38M |
| Biogena Group Invest AG | 18.43M |